Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Nabil KarahØrjan Samuelsen

Abstract

The global emergence of multidrug resistance (MDR) among Gram-negative bacteria has dramatically limited the therapeutic options. During the last two decades, Acinetobacter baumannii has become a pathogen of increased clinical importance due to its remarkable ability to cause outbreaks of infections and to acquire resistance to almost all currently used antibiotics, including the carbapenems. This review considers the literature on A. baumannii and data from multilocus sequence typing studies to explore the global population structure of A. baumannii and detect the occurrence of clonality, with the focus on the presence of specific resistance mechanisms such as the OXA-carbapenemases. The worldwide dissemination of MDR and carbapenem non-susceptible A. baumannii is associated with diverse genetic backgrounds, but predominated by a number of extensively distributed clones, such as CC92(B)/CC2(P) and CC109(B)/CC1(P), which have frequently been supplemented by acquired OXA-type carbapenemase genes.

References

Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·J VilaT Jimenez de Anta
Sep 8, 2005·Journal of Clinical Microbiology·Sergio G BartualFrancisco Rodríguez-Valera
Jan 18, 2006·PLoS Genetics·Pierre-Edouard FournierJean-Michel Claverie
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L Poirel, P Nordmann
Jan 16, 2007·Antimicrobial Agents and Chemotherapy·Stéphane CorvecPatrice Nordmann
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yohei Doi, Yoshichika Arakawa
Jul 6, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J F TurtonT L Pitt
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Sep 6, 2007·Antimicrobial Agents and Chemotherapy·Yohei DoiDavid L Paterson
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Dec 21, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K J TownerUNKNOWN ARPAC Steering Group
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B A EvansS G B Amyes
Jun 19, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H WisplinghoffH Seifert
Jun 21, 2008·International Journal of Antimicrobial Agents·Hu Lin HanYoung Jin Park
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Oct 22, 2008·Journal of Bacteriology·Mark D AdamsSteven R Gill
Apr 15, 2009·Antimicrobial Agents and Chemotherapy·Virginia Post, Ruth M Hall
May 20, 2009·Antimicrobial Agents and Chemotherapy·Carole MoubareckThierry Lambert
Jul 28, 2009·Diagnostic Microbiology and Infectious Disease·Young Kyoung ParkKwan Soo Ko
Sep 2, 2009·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Sep 16, 2009·BMC Genomics·Clara BureauDaniel Guémené
Dec 30, 2009·Antimicrobial Agents and Chemotherapy·Iraida E RobledoGuillermo J Vázquez
Jan 23, 2010·Science·Simon R HarrisStephen D Bentley
Apr 9, 2010·The Journal of Antimicrobial Chemotherapy·Virginia PostRuth M Hall
May 12, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A Di PopoloR Zarrilli
Jun 19, 2010·The Journal of Antimicrobial Chemotherapy·Lenka Krizova, Alexandr Nemec
Jul 24, 2010·The Journal of Antimicrobial Chemotherapy·Kumarasamy KarthikeyanPadma Krishnan
Jul 27, 2010·The Journal of Antimicrobial Chemotherapy·Gabriela J Da SilvaAida Duarte

❮ Previous
Next ❯

Citations

Feb 21, 2013·Antimicrobial Agents and Chemotherapy·Jessica A O'HaraYohei Doi
Nov 8, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Vranić-LadavacP Visca
Jan 1, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S JiY Yu
Apr 12, 2014·The Journal of Antimicrobial Chemotherapy·Cecilia G CarvalhaesAna C Gales
Jun 1, 2014·The Journal of Antimicrobial Chemotherapy·Noraida MosquedaUNKNOWN GEIH-GEMARA (SEIMC) and REIPI
Nov 19, 2014·Future Microbiology·Rayane RafeiMarie-Laure Joly-Guillou
Jun 6, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sofiane BakourJean-Marc Rolain
Oct 16, 2014·International Journal of Antimicrobial Agents·Stephen A Cochrane, John C Vederas
Jul 25, 2013·Expert Review of Anti-infective Therapy·John P Quinn
Mar 12, 2016·Journal of Pathogens·Ana Maria Gonzalez-Villoria, Veronica Valverde-Garduno
Oct 23, 2012·Enfermedades infecciosas y microbiología clínica·Rafael Cantón, Patricia Ruiz-Garbajosa
Jan 5, 2016·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Wenjuan WeiJiabin Li
Dec 31, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sarah E CostelloMariana Castanheira
Jul 21, 2016·Journal of Global Antimicrobial Resistance·Rym OuertaniChedly Chouchani
Mar 19, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Annalisa MilanLucilla Dolzani
Dec 25, 2012·Journal of Medical Microbiology·Agnes SonnevendTibor Pál
Aug 9, 2015·International Journal of Medical Microbiology : IJMM·Bruno Silvester LopesKen J Forbes
Aug 21, 2015·Annals of Clinical Microbiology and Antimicrobials·Essam J AlyamaniFayez S Bahwerth
Jun 2, 2014·Diagnostic Microbiology and Infectious Disease·Thiago Pavoni Gomes ChagasMarise Dutra Asensi
Jan 15, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·María Silvina StietzMariana Catalano
Oct 15, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Natacha MartinsBeatriz Meurer Moreira
Nov 2, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Gunturu RevathiLi-Yueh Huang
Jul 11, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Eduardo Carneiro ClímacoAna Lúcia da Costa Darini
Jan 7, 2015·International Journal of Antimicrobial Agents·Paola Bocanegra-IbariasElvira Garza-González
Jan 30, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zubair A QureshiYohei Doi
Jan 1, 2014·Pathogens and Disease·Luísa C S AntunesKevin J Towner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.